| Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases AF Zuluaga, BE Salazar, CA Rodriguez, AX Zapata, M Agudelo, O Vesga BMC infectious diseases 6, 1-10, 2006 | 240 | 2006 |
| Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator O Vesga, M Agudelo, BE Salazar, CA Rodriguez, AF Zuluaga Antimicrobial agents and chemotherapy 54 (8), 3271-3279, 2010 | 151 | 2010 |
| Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics AF Zuluaga, M Agudelo, CA Rodriguez, O Vesga BMC Clinical Pharmacology 9, 1-11, 2009 | 109 | 2009 |
| Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model AF Zuluaga, M Agudelo, JJ Cardeño, CA Rodriguez, O Vesga PloS one 5 (5), e10744, 2010 | 76 | 2010 |
| In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga BMC infectious diseases 10, 1-12, 2010 | 68 | 2010 |
| Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga Antimicrobial agents and chemotherapy 56 (1), 243-247, 2012 | 53 | 2012 |
| Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia CA Rodriguez, M Agudelo, JC Cataño, AF Zuluaga, O Vesga Journal of Infection 59 (4), 277-280, 2009 | 47 | 2009 |
| Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem M Agudelo, CA Rodriguez, CA Pelaez, O Vesga Antimicrobial agents and chemotherapy 58 (2), 1005-1018, 2014 | 40 | 2014 |
| Vancomycin-resistant Staphylococcus aureus CA Rodríguez, O Vesga Biomédica 25 (4), 575-587, 2005 | 40* | 2005 |
| Optimization of culture conditions to obtain maximal growth of penicillin-resistant Streptococcus pneumoniae AV Restrepo, BE Salazar, M Agudelo, CA Rodriguez, AF Zuluaga, ... BMC microbiology 5, 1-8, 2005 | 39 | 2005 |
| In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga International Journal of Antimicrobial Agents 49 (2), 189-197, 2017 | 26 | 2017 |
| Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam CA Rodriguez, M Agudelo, YA Aguilar, AF Zuluaga, O Vesga PLoS ONE 11 (5), 2016 | 24 | 2016 |
| Caracterización de los casos de accidente ofídico atendidos por el Centro de Información y Estudio de Medicamentos y Tóxicos (CIEMTO) de Medellín, Colombia durante 2016 AF García, RG Bedoya, MA Montoya, CA Rodríguez, AF Zuluaga Revista de la Universidad Industrial de Santander. Salud 49 (3), 450-457, 2017 | 22 | 2017 |
| Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin. CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga Antimicrobial Agents and Chemotherapy 59 (1), 53-58, 2015 | 22 | 2015 |
| Perspectives for the structure-based design of acetylcholinesterase reactivators RA Ochoa, CA Rodriguez, AF Zuluaga Journal of molecular graphics & modelling 68, 176-83, 2016 | 20 | 2016 |
| An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics. CA Rodriguez, M Agudelo, JM Gonzalez, O Vesga, AF Zuluaga Antimicrobial Agents and Chemotherapy 59 (1), 233-238, 2015 | 16 | 2015 |
| About the validation of animal models to study the pharmacodynamics of generic antimicrobials. AF Zuluaga, CA Rodriguez, M Agudelo, O Vesga Clinical Infectious Diseases 59 (3), 459-461, 2014 | 15 | 2014 |
| Antifungal pharmacodynamics: Latin America's perspective JM Gonzalez, CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga Brazilian Journal of Infectious Diseases 21 (1), 79-87, 2017 | 13 | 2017 |
| Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam. M Agudelo, CA Rodriguez, AF Zuluaga, O Vesga International Journal of Antimicrobial Agents 45 (2), 161-167, 2015 | 13 | 2015 |
| Experimental comparison of 11 generic products (GP) of oxacillin (OXA) with the original compound (OC) in terms of concentration of active principle (CAP), in vitro activity … CA Rodriguez, AF Zuluaga, BE Salazar, M Agudelo, O Vesga 54th interscience conference on antimicrobial agents and chemotherapy (ICAAC), 2004 | 13* | 2004 |
Andres F. ZuluagaUniversidad de Antioquia在 udea.edu.co 的电子邮件经过验证
